Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate
- PMID: 14660915
- DOI: 10.1097/00005537-200312000-00014
Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate
Abstract
Objective: Vascular endothelial growth factor (VEGF) is one of the most potent mediators of angiogenesis, which is a mandatory process during tumor growth. The present objectives were to determine expression of VEGF in vestibular schwannomas by immunohistochemistry and to examine a possible correlation with symptom duration, tumor size, or growth rate.
Study design: Retrospective patient file review; immunohistochemistry and light microscopy of vestibular schwannomas removed by surgery.
Methods: Vestibular schwannomas from 18 patients were immunolabelled using a polyclonal antibody against VEGF, followed by light microscopy and blinded semiquantitation of VEGF expression. Fifteen patients had a well-defined tumor growth rate defined by repeated preoperative magnetic resonance imaging scans.
Results: All tumors showed expression of VEGF in the Schwann cell cytoplasm, with a more intense staining of the perinuclear region of some cells. The staining intensity varied from tumor to tumor, and semiquantitation revealed a significant correlation between VEGF expression and tumor growth rate, but not symptom duration or tumor size.
Conclusion: VEGF is expressed in vestibular schwannomas and the level of expression correlates positively with tumor growth rate, but not with tumor size and symptom duration. We conclude that VEGF seems to be a factor involved in the growth of vestibular schwannomas.
Similar articles
-
Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1.Laryngoscope. 2010 Apr;120(4):657-62. doi: 10.1002/lary.20834. Laryngoscope. 2010. PMID: 20205165
-
Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics.Otol Neurotol. 2007 Dec;28(8):1094-9. doi: 10.1097/MAO.0b013e31814b2787. Otol Neurotol. 2007. PMID: 17721409
-
Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.J Oral Pathol Med. 2005 Mar;34(3):134-9. doi: 10.1111/j.1600-0714.2004.00259.x. J Oral Pathol Med. 2005. PMID: 15689226
-
[Neurotrophic factor expression in vestibular schwannoma. An overview].Laryngorhinootologie. 2006 Oct;85(10):731-7. doi: 10.1055/s-2006-925286. Epub 2006 Apr 10. Laryngorhinootologie. 2006. PMID: 16612755 Review. German.
-
The role of vascular endothelial growth factor and vascular stability in diseases of the ear.Laryngoscope. 2014 Aug;124(8):E340-6. doi: 10.1002/lary.24564. Epub 2014 Jan 28. Laryngoscope. 2014. PMID: 24347479 Review.
Cited by
-
Hypervascularized Large Vestibular Schwannomas: Single-Center Experience in a Series of Forty Cases.World Neurosurg X. 2022 Oct 4;17:100142. doi: 10.1016/j.wnsx.2022.100142. eCollection 2023 Jan. World Neurosurg X. 2022. PMID: 36341135 Free PMC article.
-
Sporadic Vestibular Schwannoma Size and Location Do not Correlate With the Severity of Hearing Loss at Initial Presentation.Front Oncol. 2022 Mar 15;12:836504. doi: 10.3389/fonc.2022.836504. eCollection 2022. Front Oncol. 2022. PMID: 35372070 Free PMC article.
-
The molecular biology of vestibular schwannomas and its association with hearing loss: a review.Genet Res Int. 2012;2012:856157. doi: 10.1155/2012/856157. Epub 2012 Feb 20. Genet Res Int. 2012. PMID: 22567403 Free PMC article.
-
The Clinical Implications of Spontaneous Hemorrhage in Vestibular Schwannomas.J Neurol Surg B Skull Base. 2021 Jul;82(Suppl 3):e22-e32. doi: 10.1055/s-0040-1701676. Epub 2020 Mar 16. J Neurol Surg B Skull Base. 2021. PMID: 34306914 Free PMC article.
-
Rationally combining anti-VEGF therapy with radiation in NF2 schwannoma.J Rare Dis Res Treat. 2016;1(2):51-55. J Rare Dis Res Treat. 2016. PMID: 28191549 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical